Lieber C S
Section of Liver Disease and Nutrition, Bronx Veterans Affairs Medical Center, New York.
Drugs. 1990;40 Suppl 3:23-44. doi: 10.2165/00003495-199000403-00004.
Two decades of research in ethanol metabolism have culminated in the molecular elucidation of an ethanol-inducible cytochrome P450 (P450IIE1) which is not only involved with ethanol metabolism and ethanol tolerance, but also with the activation of a number of xenobiotics. The unique ability of P450IIE1 to activate xenobiotic agents now appears to be responsible for the increased susceptibility of the heavy drinker to hepatotoxic industrial solvents, commonly used drugs, over-the-counter medications and chemical carcinogens. It also explains some of the interaction of ethanol with nutritional factors, such as hepatic vitamin A: enhanced microsomal degradation of retinoids (together with hepatic mobilisation) promotes depletion. Treatment, however, is complicated by the fact that ethanol also enhances the toxicity of excess vitamin A. All pathways of ethanol metabolism result in the production of acetaldehyde, the toxicity of which has been reviewed (Lieber 1982). New aspects discussed here include the formation of acetaldehyde-protein adducts and an associated immune response that may play a pathogenic role. Also discussed are the implications of ethanol-induced alterations in microtubules, mitochondria and plasma membranes, as they relate, in part, to accompanying acetaldehyde-induced toxicity, to the production of free radicals or to lipid peroxidation-mediated injury associated with glutathione depletion. There is also depletion of S-adenosyl-L-methionine (SAMe). Administration of synthetic SAMe results in a partial correction of the SAMe depletion and a consequent restoration of glutathione levels. Other beneficial effects of SAMe include a significant attenuation of the increase in plasma aspartate transaminase and glutamate dehydrogenase activities. Mitochondrial damage, including giant forms, documented by light and electron microscopy, is also attenuated by SAMe. Thus, the new understanding of the pathophysiology of alcohol-induced liver damage has led to more successful therapy with drugs and nutritional factors.
二十年来对乙醇代谢的研究最终在分子层面阐明了一种乙醇诱导的细胞色素P450(P450IIE1),它不仅参与乙醇代谢和乙醇耐受性,还与多种外源性物质的激活有关。P450IIE1激活外源性物质的独特能力现在似乎是酗酒者对肝毒性工业溶剂、常用药物、非处方药和化学致癌物易感性增加的原因。这也解释了乙醇与营养因素的一些相互作用,例如肝脏中的维生素A:类视黄醇微粒体降解增强(以及肝脏动员)会导致消耗。然而,治疗变得复杂,因为乙醇也会增强过量维生素A的毒性。乙醇代谢的所有途径都会产生乙醛,其毒性已被综述(利伯,1982年)。这里讨论的新方面包括乙醛 - 蛋白质加合物的形成以及可能起致病作用的相关免疫反应。还讨论了乙醇诱导的微管、线粒体和质膜改变的影响,因为它们部分与伴随的乙醛诱导的毒性、自由基的产生或与谷胱甘肽消耗相关的脂质过氧化介导的损伤有关。还存在S - 腺苷 - L - 甲硫氨酸(SAMe)的消耗。给予合成的SAMe会部分纠正SAMe的消耗,并随之恢复谷胱甘肽水平。SAMe的其他有益作用包括显著减轻血浆天冬氨酸转氨酶和谷氨酸脱氢酶活性的升高。光镜和电镜记录的线粒体损伤,包括巨大形态,也会被SAMe减轻。因此,对酒精性肝损伤病理生理学的新认识已导致药物和营养因素治疗更加成功。